Medical network on April 24 - affect drug firms the fate of health reform policy, come! 

 

▍ 200 medicine account for 30% of the slope to the city 

 

Only eight months, four batch of a total of 200 health reform pilot cities all public hospital medicine proportion will be cut to 30%. 

 

Yesterday (21st) afternoon, the health development planning commission website implemented on the public hospital reform work notice (countries who restructuring hair [2017] no. 22) (hereinafter referred to as "notice"), clearly put forward "by the end of 2017, the first 4 batch of pilot cities of public hospital medicine accounted (excluding Chinese medicine yinpian) to around 30% reduction in overall. 

 

This is also since 2015, the state council general office on urban public hospital comprehensive reform pilot guidance "clearly put forward in 2017, city public hospital medicine proportion control within 30%, the national level for the first time explicitly given medicine accounted for the details of implementation schedule. 

 

And this also means that the country's 200 cities have drug sales drug firms will face from varieties of research direction to marketing comprehensive business big bang. 

 

The blue note that parker directly influence in the "notice" drug related enterprise (machinery) include: 

 

By the end of 2017, the first 4 batch of pilot cities public hospital medicine proportion (excluding Chinese medicine yinpian) to around 30% overall decline; 

 

One hundred yuan of medical income (excluding drug income) of health material consumption has dropped below $20; 

 

The press disease to receive the diseases were paid no less than 100. 

 

"Mandatory drug accounted for less than 30%, which is to control drug and reduce the use simple, hard measures (binding); press macro-reforms, is to control the soft measures to reduce the use of the drug (incentive constraints simultaneously)." Yesterday, the expert inside course of study in this file to the blue parker said, "used to be called the Wolf is coming, have a clear timetable, the Wolf really come!" 

 

▍ national country medicine proportion 

 

In fact, due to excessive dependence on China's public hospital for drug sales trigger a series of problems and contradictions, as early as the ministry of health, the hospital management evaluation guideline (2008 edition) "has been put forward in? 3 armour hospital "medicine of" standard for 45% or less. ? 

 

According to the Chinese statistics yearbook 2015 health and family planning, the rising cost of the public hospital in our country, increased from 6193.9 in 2010 yuan in 2014 to 7832.3 yuan. And the costs of outpatient and inpatient expenses for medicine, accounting for half of the current national wind stress and burden increase under the background of public medical expenses, reduce the medicine proportion of urgency. 

 

In 2015, according to the medical service health system in zhejiang sunshine medical engineering implementation plan ", the requirement of medicine proportion is as follows: 

 

: the proportion of medical income drugs accounted for 45% or less of the third class hospitals, secondary hospitals 50% or less 

 

Antimicrobial drug use share: 3 first-class hospital 23% or less, 3 b, such as hospital, level 2 grade a hospital acuities were 28%, 25% or less 2 b hospitals such as 30% or less 

 

In public data, tertiary hospital a total of 121 home, there are 17 drugs account for more than 45%, there are seven antimicrobial drugs accounted for more than 23% of drug use, hospital medicine proportion has decreased obviously. 

 

As health care reform advancement, the provinces also successively introduced, such as liaoning to the requirement of medicine proportion stipulated below 40% () at the end of 2015, anhui 40% (including materials); Fujian: 35%, sanming public data shows has dropped to 27.36% from 46.77% before the reform; Jiangsu: 30% (2017), etc. 

 

▍ drug firms seismic effect 

 

And reduce the medicine proportion, in the market as the main battlefield of public hospital drug firms, especially the prescription drug sales, undoubtedly brought a seismic change. 

 

Health and family planning in China statistical yearbook 2015, according to reduce the effects of drugs at different levels of hospitals are also very different: 2014 hospitalized patients in the primary hospital need $3737.1 each time, 2 class hospital in every case to rise to 5114.6 yuan, and to a tertiary hospital is more than doubled, to 12100.0 yuan, which account for more than half of the cost is still the drug expenses. 

 

Thus, once the medicine proportion dropped to 30%, for both the hospitals and drug companies, large hole how to compensate for will be a very headache problem. 

 

Even with the personage inside course of study is expected, as the "medicine of" policy of gradually thorough, the town hospital prescription drug market over the next two years will be reduced by 10% ~ 20%. 

 

And has been in the industry believe drugs account for greater than the pressure at the grass-roots level market, the "notice" clearly put forward: 

 

By the end of 2017, to give priority to with the macro-reforms, capitation payment, pay by bed day, such as compound payment method, exploration of payment in accordance with TCM characteristics, encourage service provision and use of traditional Chinese medicine; 

 

At the county level public hospital outpatient and hospitalized patients expenses and income per capita growth drop, medical service income (excluding medicines and chemical reagents, consumables, inspect and test income) business income proportion of ascension, pay medical treatment charge of total medical costs decline. 

 

As medicine accounted for as a combination of press macro-reforms system rapidly away, such as some generic drug clinical value is not high will suffer more serious impact. 

 

More than high homogeneity lack of competitiveness of generic drug so, had to match the blue parker knew generic enterprise chief, said in the paying party macro-reforms, emphasize health control policies, such as drug economics evaluation index commonly used, including some high innovation medicine because medicare payment pressure also will experience the market challenge - the cost-effective distinctive innovation medicine may be may therefore form a new competitive and market. 

 

At the same time, each step of the hospital to deal with series of policies will also quickly to drug companies and further impact. 

 

According to the medicine proportion formula: medicine proportion = drug/(= drugs of drug income + medicine accounted/(drug income + medical income) * 100%, the hospital in order to achieve the medicine proportion is reduced, can both reduce the molecular parts, can also increase the numerator, of course, also can do both, decrease and increase the denominator at the same time. 

 

Hospital, in other words, the second negotiation will have more power, further demand can reduce medicine proportion formula of molecules; At the same time check cost ascension will help in the numerator lower drug accounted for, at the same time to fill hospital for drug sales to reduce the deficit. 

 

Public data shows that the current domestic urban public hospital medicine proportion is an average of 40%, city public hospital pharmaceutical sales amounted to 735 billion yuan in 2015, according to accounts for 40% of the drug than calculation, urban public hospitals throughout the year income in 1.84 trillion yuan. 

 

After a study conducted to measure: according to national health development planning commission, 2015 years ago may public hospital diagnosis and population growth rate of 4.9%, with the growth rate of 4.9%, medical expenses and false order time constant, then 2017 city public hospital income will increase to 2.02 trillion yuan. 

 

If medicine proportion reduced from 40% to 30%, then 2017 city public hospital pharmaceutical sales will be reduced to 606 billion from 735 billion yuan in 2015 yuan, reduce the more than 120 billion yuan. And at present in most cities in China public hospital still on average, 15% of the cost of drug addition, this part is about 90 billion yuan. 

 

All this, the research to the marketing of the drug firms put forward comprehensive challenges, outside prescribing how outflow, hospital pharmacy trusteeship is available, a medical representative sales patterns encountered what challenges, how to resolve some of the key academic department cooperation mode can rapid commercialization... The countdown has started, the time for drug firms, and the last eight months.